<DOC>
	<DOCNO>NCT03077529</DOCNO>
	<brief_summary>The population age worldwide , concomitant frailty increase old age group . Frailty strong impact outcomes multi-morbidity daily living , thereby negatively influence quality life health care cost . Prevention delay onset frailty associate age need . Dietary intake galacto-oligosaccharides ( GOS ) may beneficial effect microbiota composition health outcome parameter . As microbiota composition function may alter elderly compare young adult , investigate whether effect GOS select parameter microbiota gut health differ elderly versus young adult . The primary objective study compare effect four week GOS supplementation intestinal microbiota composition activity elderly versus young adult . Further , study four secondary objective . The study conforms randomize double-blind placebo-controlled cross-over design per age-group . Study population human volunteer ( male female ) , healthy young adult 25-50 year prefail old adult 70-85 year old , BMI 20-30 kg/m2 . One intervention period subject receive 7.2 gram Vivinal® GOS Powder three time daily four week . The intervention period subject receive isocaloric placebo supplement ( 5.7 gram maltodextrin ) three time daily four week . At start end intervention period , several measurement take place . There washout period four five week intervention period . The main study parameter change microbial composition activity induce GOS intervention , young adult elderly .</brief_summary>
	<brief_title>GOS Microbial Fermentation Aging</brief_title>
	<detailed_description />
	<criteria>1 . Based medical history gastrointestinal complaint define . 2 . Age 25 50 year classify 'robust ' Fried frailty criterion , age 70 85 year classify 'prefrail ' Fried frailty criterion . 3 . Body Mass Index ( BMI ) ≥ 20 &lt; 30 kg/m2 . 4 . Weightstable least 90 day prior participation ( change bodyweight , i.e . &lt; 3kg ) . 5 . Hemoglobin value 8.211.0 mmol/L men , 7.39.7 mmol/L woman . 6 . Creactive protein ( CRP ) value &lt; 10 mg/L . 7 . Creatinin value 60115 μmol/L men , 50100 μmol/L woman . 8 . Alanine transaminase ( ALAT ) value &lt; 45 U/L men , 34 U/L woman . 9 . Gammaglutamyl transpeptidase ( GGT ) value &lt; 55 U/L men , &lt; 38 U/L woman . 10 . Will inform case unexpected finding . 1 . History severe cardiovascular , respiratory , urogenital , gastrointestinal/ hepatic , hematological/immunologic , HEENT ( head , ears , eye , nose , throat ) , dermatological/connective tissue , musculoskeletal , metabolic/nutritional , endocrine , neurological disease , major surgery and/or laboratory assessment might limit participation completion study protocol . 2 . Selfadmitted human immunodeficiency viruspositive state . 3 . Disease life expectancy short 5 year . 4 . Abdominal surgery interfere gastrointestinal function , upon judgment medical doctor , decide exclusion base surgery apply . 5 . Use antibiotics product within 90 day prior study . 6 . Use medication review medical doctor , decide exclusion base drug ( ) use . 7 . Use laxatives within 14 day prior study . 8 . Institutionalized ( e.g . hospital nursing home ) . 9 . Pregnancy lactation . 10 . Plan lose weight follow specific diet within study period . 11 . Alcohol intake &gt; 14 units/week . 12 . Drug use . 13 . Blood donation within 30 day prior study . 14 . Administration probiotic prebiotic supplement , investigational drug participation scientific intervention study , may interfere study ( decided principle investigator ) , 14 day prior study . 15 . History side effect towards intake prebiotic supplement . 16 . Selfadmitted lactose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>